JPS6238325B2 - - Google Patents
Info
- Publication number
- JPS6238325B2 JPS6238325B2 JP59248204A JP24820484A JPS6238325B2 JP S6238325 B2 JPS6238325 B2 JP S6238325B2 JP 59248204 A JP59248204 A JP 59248204A JP 24820484 A JP24820484 A JP 24820484A JP S6238325 B2 JPS6238325 B2 JP S6238325B2
- Authority
- JP
- Japan
- Prior art keywords
- csf
- inhibitor
- medium
- cells
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 claims description 20
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 19
- 239000003112 inhibitor Substances 0.000 claims description 16
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims description 11
- 239000001963 growth medium Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 244000068988 Glycine max Species 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 230000004936 stimulating effect Effects 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 3
- 108700018667 Streptomyces subtilisin inhibitor Proteins 0.000 claims description 3
- 229940122618 Trypsin inhibitor Drugs 0.000 claims description 3
- 101710162629 Trypsin inhibitor Proteins 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 108010069594 plasminostreptin Proteins 0.000 claims description 3
- 239000002753 trypsin inhibitor Substances 0.000 claims description 3
- 108010039627 Aprotinin Proteins 0.000 claims description 2
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- 108010043846 ovoinhibitor Proteins 0.000 claims description 2
- 230000001332 colony forming effect Effects 0.000 claims 2
- 210000004027 cell Anatomy 0.000 description 29
- 239000002609 medium Substances 0.000 description 19
- 210000002966 serum Anatomy 0.000 description 17
- 230000000694 effects Effects 0.000 description 12
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 10
- 244000045232 Canavalia ensiformis Species 0.000 description 6
- 239000012980 RPMI-1640 medium Substances 0.000 description 6
- 210000000349 chromosome Anatomy 0.000 description 6
- 210000000265 leukocyte Anatomy 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 5
- 239000013587 production medium Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 4
- 210000002798 bone marrow cell Anatomy 0.000 description 3
- 230000005757 colony formation Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 210000003714 granulocyte Anatomy 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 208000008839 Kidney Neoplasms Diseases 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 206010038389 Renal cancer Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012894 fetal calf serum Substances 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 201000010982 kidney cancer Diseases 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 201000002364 leukopenia Diseases 0.000 description 2
- 231100001022 leukopenia Toxicity 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000010520 Canavalia ensiformis Nutrition 0.000 description 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 101710151905 Subtilisin inhibitor Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000035199 Tetraploidy Diseases 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 235000002098 Vicia faba var. major Nutrition 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940047120 colony stimulating factors Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000003643 myeloid progenitor cell Anatomy 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59248204A JPS61126031A (ja) | 1984-11-26 | 1984-11-26 | コロニ−形成刺激因子の製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59248204A JPS61126031A (ja) | 1984-11-26 | 1984-11-26 | コロニ−形成刺激因子の製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61126031A JPS61126031A (ja) | 1986-06-13 |
| JPS6238325B2 true JPS6238325B2 (OSRAM) | 1987-08-17 |
Family
ID=17174738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59248204A Granted JPS61126031A (ja) | 1984-11-26 | 1984-11-26 | コロニ−形成刺激因子の製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61126031A (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0519546Y2 (OSRAM) * | 1986-10-07 | 1993-05-24 | ||
| EP0958833A1 (en) * | 1998-05-20 | 1999-11-24 | Erasmus Universiteit Rotterdam | Methods and means for preventing or treating inflammation |
-
1984
- 1984-11-26 JP JP59248204A patent/JPS61126031A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61126031A (ja) | 1986-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Helmke et al. | From growth factor dependence to growth factor responsiveness: the genesis of an alveolar macrophage cell line | |
| Hara et al. | Erythropoietic precursors in mice with phenylhydrazine‐induced anemia | |
| Koller et al. | Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures | |
| US4390623A (en) | Serum-free and mitogen-free T-cell growth factor and process for making same | |
| US6939669B2 (en) | Expansion of hematopoietic cells using midkine or pleiotrophin | |
| WO1990007571A1 (en) | Method of modifying cellular differentiation and function and compositions therefor | |
| Nissen et al. | High burst-promoting activity (BPA) in serum of patients with acquired aplastic anemia | |
| CN101735979B (zh) | 体外扩增造血干细胞和前体细胞的方法 | |
| EP0241578A2 (en) | Process for replicating bone marrow in vitro | |
| JPS6238325B2 (OSRAM) | ||
| Hamburger et al. | The nature of cells generating human myeloma colonies in vitro | |
| JPH10136978A (ja) | 造血幹細胞の培養方法 | |
| CN112626017A (zh) | Nk细胞类外泌体的制备方法及其应用 | |
| EP0516845B1 (en) | Novel megakaryocytic colony stimulating factor and process for its preparation | |
| WO1990015862A1 (en) | In vitro cultivation of epithelial cells | |
| Bjornson et al. | Peripheral blood myeloid progenitor cell cultures in patients with hypereosinophilic syndrome (CFU-eos in hypereosinophilic syndrome) | |
| Grinspan et al. | Rat brain microvessel extracellular matrix modulates the phenotype of cultured rat type 1 astroglia | |
| Cobleigh et al. | Growth of human squamous head and neck cancer in vitro | |
| CN115386551B (zh) | 小鼠骨髓造血干/祖细胞体外衰老细胞模型的应用 | |
| JP3594208B2 (ja) | 血液細胞培養支持体、血液細胞製造方法及び血液細胞製造用原料組成物 | |
| JPH11180877A (ja) | 巨核球前駆細胞を含む細胞製剤及びその製造方法 | |
| JPS6314947B2 (OSRAM) | ||
| JP2002171967A (ja) | 造血細胞群の体外培養方法 | |
| US20070281352A1 (en) | Peripheral blood mononuclear cells | |
| CN119931935A (zh) | 一种胎盘来源造血干细胞诱导nk细胞的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |